Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission - PubMed (original) (raw)
Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission
A Guerrasio et al. Br J Haematol. 1995 Jun.
Abstract
The t(8;21) (q22;q22) translocation is a recurring chromosomal abnormality observed in about 20-40% of AML patients with subtype FAB M2 (AML-M2). The molecular facet of this translocation is represented by the formation of a new hybrid gene, the AML1-ETO, which is regularly transcribed in a chimaeric mRNA and translated into a new fusion protein believed to have a key role in the pathogenesis of this type of leukaemia. We looked for the presence of AML1-ETO transcripts, by RT-PCR, in 49 unselected patients affected by AML-M2 diagnosed at various Italian Institutions. A hybrid transcript was detected in 11 cases (23%). Minimal residual disease status was investigated in three patients in continuous complete remission (CCR) after a median follow-up of 44 months; at least one sample from each subject was found positive for the AML1-ETO transcript suggesting a long-term persistence of t(8;21) leukaemic cells. In two female patients in CCR a 'clonality' analysis was performed on peripheral blood DNA by exploiting the X chromosome inactivation pattern of the human androgen-receptor gene (HUMARA); in both cases the results were consistent with the presence of a polyclonal haemopoiesis. Our data confirm that the persistence of residual cells expressing the AML1-ETO transcripts is a frequent occurrence even in patients with long-term remission; on the other hand, clonality assays indicate that in t(8;21) leukaemias long-term remission haemopoiesis is sustained by a polyclonal bone marrow reconstitution.
Similar articles
- Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T, Takenaka K, Mizuno S, Gondo H, Okamura T, Dohy H, Niho Y. Miyamoto T, et al. Blood. 1996 Jun 1;87(11):4789-96. Blood. 1996. PMID: 8639850 - Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
Kwong YL, Chan V, Wong KF, Chan TK. Kwong YL, et al. Cancer. 1995 Feb 1;75(3):821-5. doi: 10.1002/1097-0142(19950201)75:3<821::aid-cncr2820750312>3.0.co;2-z. Cancer. 1995. PMID: 7828132 - The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
Nucifora G, Rowley JD. Nucifora G, et al. Leuk Lymphoma. 1994 Aug;14(5-6):353-62. doi: 10.3109/10428199409049690. Leuk Lymphoma. 1994. PMID: 7812194 Review. - Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffmann L, Ball ED, Frei-Lahr DA, Christiansen NP, Block AM, Knuutila S, Herzig GP, Bloomfield CD. Jurlander J, et al. Blood. 1996 Sep 15;88(6):2183-91. Blood. 1996. PMID: 8822938 - The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F, Pisegna S, Diverio D. Lo Coco F, et al. Haematologica. 1997 May-Jun;82(3):364-70. Haematologica. 1997. PMID: 9234595 Review.
Cited by
- Measurements of treatment response in childhood acute leukemia.
Campana D, Coustan-Smith E. Campana D, et al. Korean J Hematol. 2012 Dec;47(4):245-54. doi: 10.5045/kjh.2012.47.4.245. Epub 2012 Dec 24. Korean J Hematol. 2012. PMID: 23320002 Free PMC article. - Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.
Alarcón-Riquelme ME. Alarcón-Riquelme ME. Arthritis Res Ther. 2004;6(4):169-73. doi: 10.1186/ar1203. Epub 2004 Jun 21. Arthritis Res Ther. 2004. PMID: 15225361 Free PMC article. Review. - AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.
Miyamoto T, Weissman IL, Akashi K. Miyamoto T, et al. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7521-6. doi: 10.1073/pnas.97.13.7521. Proc Natl Acad Sci U S A. 2000. PMID: 10861016 Free PMC article. - Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling.
Spirin PV, Lebedev TD, Orlova NN, Gornostaeva AS, Prokofjeva MM, Nikitenko NA, Dmitriev SE, Buzdin AA, Borisov NM, Aliper AM, Garazha AV, Rubtsov PM, Stocking C, Prassolov VS. Spirin PV, et al. Leukemia. 2014 Nov;28(11):2222-8. doi: 10.1038/leu.2014.130. Epub 2014 Apr 14. Leukemia. 2014. PMID: 24727677 - Monitoring of acute myeloid leukemia by flow cytometry.
Kern W, Schnittger S. Kern W, et al. Curr Oncol Rep. 2003 Sep;5(5):405-12. doi: 10.1007/s11912-003-0027-5. Curr Oncol Rep. 2003. PMID: 12895393
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical